\-\ Texto\\:\\ \ \(0\)\
\-\ she\\ is\\ to\\ follow\\ up\\ on\\ an\\ outpatient\\ basis\\ to\\ have\\ a\\ flexible\\ sigmoidoscopy\\ performed\\.\ \(0\)\
\-\ markedly\\ abnormal\\ appearance\\ of\\ the\\ majority\\ of\\ the\\ colon\\ consistent\\ with\\ pneumatosis\\ intestinalis\\.\\ \\ multiple\\ cystic\\ lucencies\\ are\\ present\\ diffusely\\ within\\ the\\ colonic\\ wall\\ with\\ sparing\\ of\\ the\\ distal\\ descending\\ and\\ distal\\ transverese\\ colon\\.\\ \\ cystic\\ changes\\ are\\ most\\ pronounced\\ at\\ the\\ hepatic\\ and\\ splenic\\ flexures\\.\ \(0\)\
\-\ pneumatosis\\ cystoides\\ coli\ \(0\)\
\-\ mucosal\\ disruption\ \(1\)\
\-\ \\â\\€\\¢\\ idiopathic\ \(0\)\
\-\ \\â\\€\\¢\\ trama\\ \\:\\ s\\/p\\ endoscopy\\,\\ surgery\ \(0\)\
\-\ \\â\\€\\¢\\ infection\\/inflammation\\:\\ crohn\\'s\\,\\ ulceratice\\ colitis\\,\\ c\\.\\ difficile\\ infection\\.\ \(0\)\
\-\ pulmonary\\ disease\\/process\ \(0\)\
\-\ \\â\\€\\¢\\ bronchopleural\\ fistula\ \(0\)\
\-\ \\â\\€\\¢\\ copd\\-\\ chronic\\ bronchitis\\,\\ bullous\\ lung\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ asthma\ \(0\)\
\-\ \\â\\€\\¢\\ trauma\\-\\ barotrauma\\,\\ chest\\ tube\ \(0\)\
\-\ increased\\ mucosal\\ permeability\ \(1\)\
\-\ \\â\\€\\¢\\ s\\/p\\ chemotherapy\\ or\\ radiation\ \(1\)\
\-\ \\â\\€\\¢\\ collagen\\ vascular\\ disease\ \(1\)\
\-\ other\ \(2221\)\
\-\ \\â\\€\\¢\\ gas\\ in\\ the\\ lumen\\ of\\ the\\ bowel\ \(0\)\
\-\ 33\\ y\\.o\\.\\ woman\\ with\\ a\\ history\\ of\\ mediastinal\\ b\\-cell\\ lymphoma\\ that\\ was\\ diagnosed\\ six\\ years\\ ago\\.\\ \\ she\\ has\\ received\\ chemotherapy\\ consisting\\ of\\ bleomycin\\,\\ doxyrubicin\\,\\ and\\ cytoxin\\,\\ as\\ well\\ as\\ localized\\ radiation\\.\\ \\ her\\ clinical\\ course\\ was\\ subsequently\\ complicated\\ by\\ a\\ paralyzed\\ right\\ hemi\\ diaphragm\\.\\ \\ three\\ years\\ ago\\ she\\ was\\ diagnosed\\ with\\ mac\\ and\\ treated\\ with\\ rifabutin\\ and\\ clarithromycin\\ for\\ approx\\ 3\\ years\\ with\\ persistent\\ cultures\\ after\\ 18\\ months\\ of\\ therapy\\.\\ \\ she\\ has\\ also\\ been\\ treated\\ with\\ methotrexate\\ and\\ prednisone\\ for\\ recurrent\\ episodes\\ of\\ scleritis\\ of\\ which\\ an\\ autoimmune\\ work\\ up\\ has\\ been\\ negative\\.\\ \\ \\ she\\ was\\ admitted\\ at\\ the\\ beginning\\ of\\ august\\ for\\ increased\\ cough\\ and\\ hemoptysis\\ as\\ well\\ as\\ bloody\\ diarrhea\\.\\ \\ at\\ the\\ time\\ of\\ admission\\ she\\ also\\ had\\ a\\ complaint\\ of\\ increased\\ eye\\ pain\\.\\ \\ in\\ brief\\,\\ during\\ her\\ admission\\ she\\ was\\ evaluated\\ by\\ infectious\\ disease\\ who\\ made\\ no\\ changes\\ to\\ her\\ mac\\ therapy\\ medications\\,\\ ophthalmology\\ was\\ concerned\\ for\\ worsening\\ scleritis\\ and\\ increased\\ her\\ oral\\ steroids\\ to\\ 40mg\\ qd\\,\\ cardiothoracic\\ surgery\\ who\\ discussed\\ possible\\ resection\\ of\\ her\\ damaged\\ rul\\ and\\ chronic\\ infections\\,\\ as\\ well\\ as\\ pulmonary\\ who\\ performed\\ a\\ bronchoscopy\\ to\\ obtain\\ cultures\\ as\\ well\\ as\\ to\\ localized\\ her\\ hemoptysis\\.\\ \\ no\\ evidence\\ of\\ bleeding\\ was\\ noted\\ and\\ her\\ cultures\\ of\\ the\\ rul\\ have\\ grown\\ aspergillus\\ niger\\.\\ her\\ mac\\ cultures\\ are\\ still\\ pending\\ at\\ this\\ time\\.\\ \\ she\\ was\\ also\\ evaluated\\ during\\ this\\ admission\\ by\\ gi\\ for\\ her\\ diarrhea\\ and\\ her\\ incidental\\ finding\\ of\\ pneumatosis\\ cystoides\\ coli\\.\ \(0\)\
\-\ the\\ exact\\ time\\ of\\ onset\\ of\\ this\\ patient\\â\\€\\™s\\ pneumatosis\\ is\\ not\\ clear\\.\\ \\ while\\ literature\\ case\\ studies\\ do\\ report\\ an\\ association\\ of\\ pneumatosis\\ intestinalis\\ with\\ chemotheraputic\\ agents\\ such\\ at\\ etoposide\\,\\ this\\ drug\\ was\\ not\\ included\\ in\\ her\\ treatment\\ regimen\\.\\ further\\ investigation\\ of\\ her\\ medical\\ imaging\\ and\\ medication\\ history\\ would\\ be\\ useful\\ to\\ identify\\ the\\ time\\ of\\ onset\\ in\\ order\\ to\\ attempt\\ to\\ correlate\\ these\\ findings\\ with\\ a\\ specific\\ medication\\ of\\ other\\ medical\\ intervention\\.\\ \\ a\\ pubmed\\ mesh\\ literature\\ search\\ for\\ mac\\ associated\\ pneumatosis\\ intestinalis\\ did\\ not\\ produce\\ any\\ results\\.\\ \\ while\\ she\\ does\\ complain\\ of\\ diarrhea\\,\\ obviously\\ a\\ very\\ nonspecific\\ symptom\\,\\ she\\ does\\ not\\ display\\ a\\ clinical\\ appearance\\ or\\ evidence\\ of\\ an\\ intraabdominal\\ catastrophe\\.\\ \\ therefore\\,\\ she\\ most\\ likely\\ suffers\\ from\\ a\\ benign\\ course\\ of\\ pneumatosis\\ intestinalis\\ and\\ should\\ only\\ be\\ treated\\ if\\ she\\ becomes\\ significantly\\ symptomatic\\.\\ \\ treatment\\ options\\,\\ outlined\\ in\\ the\\ topic\\ introduction\\,\\ include\\ high\\-flow\\ oxygen\\ therapy\\,\\ hyperbaric\\ oxygen\\ therapy\\,\\ antibiotics\\ and\\ special\\ diets\\.\ \(0\)\
\-\ goldberg\\,\\ e\\.\\,\\ lamont\\,\\ jt\\.\\ \\(2009\\)\\.\\ pneumatosis\\ intestinalis\\.\\ in\\ b\\.\\ rose\\ \\(ed\\.\\)\\,uptodate\\.\\ available\\ from\\ http\\:\\/\\/www\\.uptodateonline\\.com\\.\\ \ \(0\)\
\-\ emedicine\\.\\ pneumatosis\\ intestinalis\\.\\(n\\.d\\)\\.retrieved\\ july\\ 10\\,\\ 2009\\,\\ from\\ http\\:\\/\\/emedicine\\.medscape\\.com\\/article\\/371955\\-overview\ \(0\)\
\-\ hashimoto\\,\\ s\\.\\,\\ hiroyuki\\,\\ s\\.\\,\\ wada\\,\\ k\\.\\,\\ kobayashi\\,\\ t\\.\\,\\ hiroshi\\,\\ f\\.\\,\\ hirokazu\\,\\ k\\.\\,\\ et\\ al\\.\\ \\(1995\\)\\.\\ pneumatosis\\ cystoides\\ intestinalis\\ after\\ chemotherapy\\ for\\ hematological\\ malignancies\\:\\ report\\ of\\ 4\\ cases\\.\\ internal\\ medicine\\ 34\\,\\ 212\\-215\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pneumatosis\\:\\ 0\\.37735899461427597\ \(0\)\
\-\ intestinalis\\:\\ 0\\.2857053505463541\ \(0\)\
\-\ her\\:\\ 0\\.25777946169845095\ \(0\)\
\-\ she\\:\\ 0\\.24562084739119536\ \(0\)\
\-\ mac\\:\\ 0\\.19786176448882628\ \(0\)\
\-\ of\\:\\ 0\\.17495236961229768\ \(0\)\
\-\ cystoides\\:\\ 0\\.14509933409333137\ \(0\)\
\-\ cultures\\:\\ 0\\.12954968138649872\ \(0\)\
\-\ as\\:\\ 0\\.11050849523891453\ \(0\)\
\-\ scleritis\\:\\ 0\\.10997730216068857\ \(0\)\
\-\ was\\:\\ 0\\.10785073462085897\ \(0\)\
\-\ and\\:\\ 0\\.09947253663292709\ \(0\)\
\-\ diarrhea\\:\\ 0\\.09759283795416587\ \(0\)\
\-\ the\\:\\ 0\\.0891929653873681\ \(0\)\
\-\ admission\\:\\ 0\\.08606640007144638\ \(0\)\
\-\ rul\\:\\ 0\\.08417755469162967\ \(0\)\
\-\ coli\\:\\ 0\\.08163010015610116\ \(0\)\
\-\ time\\:\\ 0\\.0815227599495246\ \(0\)\
\-\ therapy\\:\\ 0\\.07902500436274555\ \(0\)\
\-\ to\\:\\ 0\\.0773650096253631\ \(0\)\
\-\ increased\\:\\ 0\\.07437448381681123\ \(0\)\
\-\ 2009\\:\\ 0\\.07416722095977087\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.07324627565994847\ \(0\)\
\-\ for\\:\\ 0\\.0729522108271228\ \(0\)\
\-\ hemoptysis\\:\\ 0\\.07117187416392795\ \(0\)\
\-\ oxygen\\:\\ 0\\.07069904556069546\ \(0\)\
\-\ emedicine\\:\\ 0\\.06838568739096682\ \(0\)\
\-\ literature\\:\\ 0\\.06711550484075032\ \(0\)\
\-\ well\\:\\ 0\\.06659700155686402\ \(0\)\
\-\ at\\:\\ 0\\.06493771811949324\ \(0\)\
\-\ mucosal\\:\\ 0\\.06477484069324936\ \(0\)\
\-\ treated\\:\\ 0\\.06423700823901081\ \(0\)\
\-\ medication\\:\\ 0\\.06356152421088902\ \(0\)\
\-\ years\\:\\ 0\\.06323211772360843\ \(0\)\
\-\ localized\\:\\ 0\\.06177665762306504\ \(0\)\
\-\ with\\:\\ 0\\.0605966204808873\ \(0\)\
\-\ evaluated\\:\\ 0\\.058759210758645444\ \(0\)\
\-\ who\\:\\ 0\\.05835035911375651\ \(0\)\
\-\ report\\:\\ 0\\.05792746139879361\ \(0\)\
\-\ disease\\:\\ 0\\.05773393385397868\ \(0\)\
\-\ transverese\\:\\ 0\\.054988651080344286\ \(0\)\
\-\ trama\\:\\ 0\\.054988651080344286\ \(0\)\
\-\ ulceratice\\:\\ 0\\.054988651080344286\ \(0\)\
\-\ cytoxin\\:\\ 0\\.054988651080344286\ \(0\)\
\-\ rifabutin\\:\\ 0\\.054988651080344286\ \(0\)\
\-\ chemotheraputic\\:\\ 0\\.054988651080344286\ \(0\)\
\-\ catastrophe\\:\\ 0\\.054988651080344286\ \(0\)\
\-\ lamont\\:\\ 0\\.054988651080344286\ \(0\)\
\-\ hiroyuki\\:\\ 0\\.054988651080344286\ \(0\)\
\-\ kobayashi\\:\\ 0\\.054988651080344286\ \(0\)\
\-\ hiroshi\\:\\ 0\\.054988651080344286\ \(0\)\
\-\ hirokazu\\:\\ 0\\.054988651080344286\ \(0\)\
\-\ not\\:\\ 0\\.054297076364469406\ \(0\)\
\-\ an\\:\\ 0\\.052594404333037637\ \(0\)\
\-\ paralyzed\\:\\ 0\\.052544591738829555\ \(0\)\
\-\ niger\\:\\ 0\\.052544591738829555\ \(0\)\
\-\ wada\\:\\ 0\\.052544591738829555\ \(0\)\
\-\ colon\\:\\ 0\\.05236217728796684\ \(0\)\
\-\ in\\:\\ 0\\.051322812805477\ \(0\)\
\-\ http\\:\\ 0\\.05084134986690524\ \(0\)\
\-\ sigmoidoscopy\\:\\ 0\\.05081050403929185\ \(0\)\
\-\ flexures\\:\\ 0\\.05081050403929185\ \(0\)\
\-\ doxyrubicin\\:\\ 0\\.05081050403929185\ \(0\)\
\-\ clarithromycin\\:\\ 0\\.05081050403929185\ \(0\)\
\-\ diets\\:\\ 0\\.05081050403929185\ \(0\)\
\-\ hematological\\:\\ 0\\.05081050403929185\ \(0\)\
\-\ course\\:\\ 0\\.0507967820378385\ \(0\)\
\-\ ago\\:\\ 0\\.05031711144575469\ \(0\)\
\-\ diagnosed\\:\\ 0\\.04981472275243833\ \(0\)\
\-\ permeability\\:\\ 0\\.04946544112220657\ \(0\)\
\-\ 40mg\\:\\ 0\\.04946544112220657\ \(0\)\
\-\ goldberg\\:\\ 0\\.04946544112220657\ \(0\)\
\-\ rose\\:\\ 0\\.04946544112220657\ \(0\)\
\-\ also\\:\\ 0\\.04852075897113418\ \(0\)\
\-\ bleomycin\\:\\ 0\\.048366444697777115\ \(0\)\
\-\ does\\:\\ 0\\.047541786783254665\ \(0\)\
\-\ bronchopleural\\:\\ 0\\.047437256460617756\ \(0\)\
\-\ bullous\\:\\ 0\\.047437256460617756\ \(0\)\
\-\ hyperbaric\\:\\ 0\\.047437256460617756\ \(0\)\
\-\ this\\:\\ 0\\.0472608345148353\ \(0\)\
\-\ has\\:\\ 0\\.04711781310695186\ \(0\)\
\-\ flexible\\:\\ 0\\.046632356998239415\ \(0\)\
\-\ barotrauma\\:\\ 0\\.046632356998239415\ \(0\)\
\-\ mesh\\:\\ 0\\.046632356998239415\ \(0\)\
\-\ introduction\\:\\ 0\\.046632356998239415\ \(0\)\
\-\ etoposide\\:\\ 0\\.045922385356262384\ \(0\)\
\-\ obviously\\:\\ 0\\.045922385356262384\ \(0\)\
\-\ jt\\:\\ 0\\.045922385356262384\ \(0\)\
\-\ radiation\\:\\ 0\\.04557234265662413\ \(0\)\
\-\ difficile\\:\\ 0\\.04528729408115413\ \(0\)\
\-\ cardiothoracic\\:\\ 0\\.04471278414026406\ \(0\)\
\-\ suffers\\:\\ 0\\.04471278414026406\ \(0\)\
\-\ while\\:\\ 0\\.044444316396226646\ \(0\)\
\-\ onset\\:\\ 0\\.04415881021250872\ \(0\)\
\-\ by\\:\\ 0\\.04380523759464641\ \(0\)\
\-\ aspergillus\\:\\ 0\\.043705816862452604\ \(0\)\
\-\ medical\\:\\ 0\\.04370572868008366\ \(0\)\
\-\ clinical\\:\\ 0\\.04358283685106718\ \(0\)\
\-\ during\\:\\ 0\\.04355840810100123\ \(0\)\
\-\ grown\\:\\ 0\\.04325910941956532\ \(0\)\
\-\ intraabdominal\\:\\ 0\\.04325910941956532\ \(0\)\
\-\ bronchitis\\:\\ 0\\.0428432347396394\ \(0\)\
\-\ damaged\\:\\ 0\\.0428432347396394\ \(0\)\
\-\ hashimoto\\:\\ 0\\.0428432347396394\ \(0\)\
\-\ outlined\\:\\ 0\\.042454209957186975\ \(0\)\
\-\ pulmonary\\:\\ 0\\.04191814268534583\ \(0\)\
\-\ changes\\:\\ 0\\.04156138048329419\ \(0\)\
\-\ infection\\:\\ 0\\.04154071966584233\ \(0\)\
\-\ appearance\\:\\ 0\\.04145842867033346\ \(0\)\
\-\ cystic\\:\\ 0\\.041417492861790535\ \(0\)\
\-\ brief\\:\\ 0\\.0411091470401017\ \(0\)\
\-\ from\\:\\ 0\\.040968457747438784\ \(0\)\
\-\ chronic\\:\\ 0\\.04081957277013174\ \(0\)\
\-\ display\\:\\ 0\\.04081505007805058\ \(0\)\
\-\ performed\\:\\ 0\\.04068422397359467\ \(0\)\
\-\ ophthalmology\\:\\ 0\\.04053463709921162\ \(0\)\
\-\ hemi\\:\\ 0\\.040266691119679746\ \(0\)\
\-\ concerned\\:\\ 0\\.040266691119679746\ \(0\)\
\-\ investigation\\:\\ 0\\.040266691119679746\ \(0\)\
\-\ been\\:\\ 0\\.040065853352803715\ \(0\)\
\-\ uptodate\\:\\ 0\\.040010150615672244\ \(0\)\
\-\ distal\\:\\ 0\\.03995675230021338\ \(0\)\
\-\ qd\\:\\ 0\\.039764084123016415\ \(0\)\
\-\ approx\\:\\ 0\\.03930017897369522\ \(0\)\
\-\ special\\:\\ 0\\.03930017897369522\ \(0\)\
\-\ are\\:\\ 0\\.03914231103321052\ \(0\)\
\-\ pubmed\\:\\ 0\\.03908096237851288\ \(0\)\
\-\ july\\:\\ 0\\.03908096237851288\ \(0\)\
\-\ evidence\\:\\ 0\\.03903363589089953\ \(0\)\
\-\ methotrexate\\:\\ 0\\.03866508769858696\ \(0\)\
\-\ malignancies\\:\\ 0\\.03866508769858696\ \(0\)\
\-\ pronounced\\:\\ 0\\.0384674374663609\ \(0\)\
\-\ autoimmune\\:\\ 0\\.0384674374663609\ \(0\)\
\-\ bloody\\:\\ 0\\.0384674374663609\ \(0\)\
\-\ obtain\\:\\ 0\\.0384674374663609\ \(0\)\
\-\ consisting\\:\\ 0\\.038276062916134536\ \(0\)\
\-\ regimen\\:\\ 0\\.038090577757696885\ \(0\)\
\-\ complain\\:\\ 0\\.038090577757696885\ \(0\)\
\-\ beginning\\:\\ 0\\.0379106303047624\ \(0\)\
\-\ correlate\\:\\ 0\\.0379106303047624\ \(0\)\
\-\ exact\\:\\ 0\\.037735899461427594\ \(0\)\
\-\ august\\:\\ 0\\.03756609127415751\ \(0\)\
\-\ bronchoscopy\\:\\ 0\\.03756609127415751\ \(0\)\
\-\ 1995\\:\\ 0\\.03708361047988543\ \(0\)\
\-\ surgery\\:\\ 0\\.036973358403123956\ \(0\)\
\-\ basis\\:\\ 0\\.036782158066017125\ \(0\)\
\-\ lucencies\\:\\ 0\\.036636903036998146\ \(0\)\
\-\ identify\\:\\ 0\\.036636903036998146\ \(0\)\
\-\ prednisone\\:\\ 0\\.03622102835707223\ \(0\)\
\-\ sparing\\:\\ 0\\.036088544078627306\ \(0\)\
\-\ agents\\:\\ 0\\.03595890914649695\ \(0\)\
\-\ search\\:\\ 0\\.035832003574619804\ \(0\)\
\-\ most\\:\\ 0\\.03578969785802932\ \(0\)\
\-\ other\\:\\ 0\\.03571307312528967\ \(0\)\
\-\ endoscopy\\:\\ 0\\.035585937081963975\ \(0\)\
\-\ attempt\\:\\ 0\\.035466570963247665\ \(0\)\
\-\ outpatient\\:\\ 0\\.035234704222779765\ \(0\)\
\-\ symptom\\:\\ 0\\.0350114271410739\ \(0\)\
\-\ collagen\\:\\ 0\\.03490281533746044\ \(0\)\
\-\ produce\\:\\ 0\\.03448694065753452\ \(0\)\
\-\ have\\:\\ 0\\.03435410628296946\ \(0\)\
\-\ asthma\\:\\ 0\\.03428929042530846\ \(0\)\
\-\ discussed\\:\\ 0\\.034097915875082103\ \(0\)\
\-\ up\\:\\ 0\\.03401764954257986\ \(0\)\
\-\ colitis\\:\\ 0\\.03400445986326245\ \(0\)\
\-\ splenic\\:\\ 0\\.03373248326370996\ \(0\)\
\-\ colonic\\:\\ 0\\.03355775242037516\ \(0\)\
\-\ crohn\\:\\ 0\\.03347225039081749\ \(0\)\
\-\ after\\:\\ 0\\.03336118159918026\ \(0\)\
\-\ diaphragm\\:\\ 0\\.03330480095607847\ \(0\)\
\-\ becomes\\:\\ 0\\.032905463438833\ \(0\)\
\-\ topic\\:\\ 0\\.032905463438833\ \(0\)\
\-\ useful\\:\\ 0\\.03282867524095725\ \(0\)\
\-\ treatment\\:\\ 0\\.032758532237777596\ \(0\)\
\-\ complicated\\:\\ 0\\.03260401102496469\ \(0\)\
\-\ nonspecific\\:\\ 0\\.03231691905151859\ \(0\)\
\-\ significantly\\:\\ 0\\.03231691905151859\ \(0\)\
\-\ diffusely\\:\\ 0\\.03197627520167363\ \(0\)\
\-\ order\\:\\ 0\\.03178076210544451\ \(0\)\
\-\ episodes\\:\\ 0\\.031407790040911536\ \(0\)\
\-\ drug\\:\\ 0\\.031288423922195226\ \(0\)\
\-\ majority\\:\\ 0\\.0312296157287506\ \(0\)\
\-\ descending\\:\\ 0\\.031056557181727326\ \(0\)\
\-\ disruption\\:\\ 0\\.031056557181727326\ \(0\)\
\-\ fistula\\:\\ 0\\.031056557181727326\ \(0\)\
\-\ options\\:\\ 0\\.03099995777981208\ \(0\)\
\-\ association\\:\\ 0\\.03094388489159034\ \(0\)\
\-\ six\\:\\ 0\\.03088832881153252\ \(0\)\
\-\ lumen\\:\\ 0\\.030617978926877565\ \(0\)\
\-\ still\\:\\ 0\\.030461404097318266\ \(0\)\
\-\ markedly\\:\\ 0\\.03035923568503586\ \(0\)\
\-\ infections\\:\\ 0\\.03035923568503586\ \(0\)\
\-\ therefore\\:\\ 0\\.030308793616482085\ \(0\)\
\-\ medicine\\:\\ 0\\.030308793616482085\ \(0\)\
\-\ 33\\:\\ 0\\.030258770159131393\ \(0\)\
\-\ steroids\\:\\ 0\\.030209158422146706\ \(0\)\
\-\ gas\\:\\ 0\\.030111143384256026\ \(0\)\
\-\ 34\\:\\ 0\\.02996704587651112\ \(0\)\
\-\ received\\:\\ 0\\.029919768834029668\ \(0\)\
\-\ complaint\\:\\ 0\\.029780122619052874\ \(0\)\
\-\ included\\:\\ 0\\.029734283675592013\ \(0\)\
\-\ subsequently\\:\\ 0\\.02933670276392978\ \(0\)\
\-\ idiopathic\\:\\ 0\\.029085508417271606\ \(0\)\
\-\ gi\\:\\ 0\\.028883891227339857\ \(0\)\
\-\ intervention\\:\\ 0\\.028883891227339857\ \(0\)\
\-\ medications\\:\\ 0\\.02884436458068049\ \(0\)\
\-\ do\\:\\ 0\\.028499825550075606\ \(0\)\
\-\ pending\\:\\ 0\\.028280608954893267\ \(0\)\
\-\ admitted\\:\\ 0\\.02817391958536283\ \(0\)\
\-\ bleeding\\:\\ 0\\.02810382819077142\ \(0\)\
\-\ work\\:\\ 0\\.02803454246223744\ \(0\)\
\-\ be\\:\\ 0\\.027897011654963725\ \(0\)\
\-\ mediastinal\\:\\ 0\\.02776509908063197\ \(0\)\
\-\ infectious\\:\\ 0\\.027667084042741295\ \(0\)\
\-\ recurrent\\:\\ 0\\.02757063731291624\ \(0\)\
\-\ oral\\:\\ 0\\.02753882831025458\ \(0\)\
\-\ eye\\:\\ 0\\.02750718628475372\ \(0\)\
\-\ ed\\:\\ 0\\.02750718628475372\ \(0\)\
\-\ tube\\:\\ 0\\.02747570949251493\ \(0\)\
\-\ hepatic\\:\\ 0\\.027382253480695277\ \(0\)\
\-\ al\\:\\ 0\\.027320744865186722\ \(0\)\
\-\ et\\:\\ 0\\.02693554603780799\ \(0\)\
\-\ results\\:\\ 0\\.026793709093380868\ \(0\)\
\-\ made\\:\\ 0\\.026519671357882076\ \(0\)\
\-\ persistent\\:\\ 0\\.02649294052908119\ \(0\)\
\-\ symptomatic\\:\\ 0\\.026439831885825126\ \(0\)\
\-\ history\\:\\ 0\\.026273906344714364\ \(0\)\
\-\ worsening\\:\\ 0\\.026257552147306792\ \(0\)\
\-\ 18\\:\\ 0\\.026055766208560878\ \(0\)\
\-\ specific\\:\\ 0\\.026055766208560878\ \(0\)\
\-\ cough\\:\\ 0\\.025671394295514495\ \(0\)\
\-\ incidental\\:\\ 0\\.025488025265592955\ \(0\)\
\-\ antibiotics\\:\\ 0\\.025332029335627497\ \(0\)\
\-\ studies\\:\\ 0\\.02522302470122656\ \(0\)\
\-\ clear\\:\\ 0\\.024927899017948233\ \(0\)\
\-\ did\\:\\ 0\\.02466621753962805\ \(0\)\
\-\ very\\:\\ 0\\.02466621753962805\ \(0\)\
\-\ would\\:\\ 0\\.024340311574915282\ \(0\)\
\-\ or\\:\\ 0\\.02392366286891243\ \(0\)\
\-\ benign\\:\\ 0\\.023619981119568756\ \(0\)\
\-\ available\\:\\ 0\\.023329039243701288\ \(0\)\
\-\ possible\\:\\ 0\\.023297562451462493\ \(0\)\
\-\ internal\\:\\ 0\\.023173273676681466\ \(0\)\
\-\ cases\\:\\ 0\\.02312731824176709\ \(0\)\
\-\ three\\:\\ 0\\.02308171051839165\ \(0\)\
\-\ vascular\\:\\ 0\\.02270026309962245\ \(0\)\
\-\ finding\\:\\ 0\\.022601560206273574\ \(0\)\
\-\ should\\:\\ 0\\.022436026911170578\ \(0\)\
\-\ further\\:\\ 0\\.022395344245946015\ \(0\)\
\-\ no\\:\\ 0\\.022363038657448105\ \(0\)\
\-\ any\\:\\ 0\\.022222158198113323\ \(0\)\
\-\ such\\:\\ 0\\.022118003692891616\ \(0\)\
\-\ bowel\\:\\ 0\\.02206659364124829\ \(0\)\
\-\ resection\\:\\ 0\\.022041052111438357\ \(0\)\
\-\ only\\:\\ 0\\.02148162180820425\ \(0\)\
\-\ negative\\:\\ 0\\.021287344396368098\ \(0\)\
\-\ wall\\:\\ 0\\.02091662192768741\ \(0\)\
\-\ lung\\:\\ 0\\.02091662192768741\ \(0\)\
\-\ abnormal\\:\\ 0\\.0206578786858457\ \(0\)\
\-\ likely\\:\\ 0\\.020547458092416346\ \(0\)\
\-\ lymphoma\\:\\ 0\\.020478229203301848\ \(0\)\
\-\ include\\:\\ 0\\.020458594684259798\ \(0\)\
\-\ 10\\:\\ 0\\.020106437246192536\ \(0\)\
\-\ months\\:\\ 0\\.020014688260017812\ \(0\)\
\-\ if\\:\\ 0\\.01997837615010669\ \(0\)\
\-\ these\\:\\ 0\\.01941704531698913\ \(0\)\
\-\ is\\:\\ 0\\.018832977756146202\ \(0\)\
\-\ consistent\\:\\ 0\\.018644183915888745\ \(0\)\
\-\ follow\\:\\ 0\\.01853634934031017\ \(0\)\
\-\ noted\\:\\ 0\\.018230727607917527\ \(0\)\
\-\ chest\\:\\ 0\\.01814999704383202\ \(0\)\
\-\ associated\\:\\ 0\\.018123325354226102\ \(0\)\
\-\ imaging\\:\\ 0\\.018070333434768077\ \(0\)\
\-\ woman\\:\\ 0\\.0179076740232491\ \(0\)\
\-\ present\\:\\ 0\\.017643916046398183\ \(0\)\
\-\ case\\:\\ 0\\.01727450886798987\ \(0\)\
\-\ had\\:\\ 0\\.01713173118348808\ \(0\)\
\-\ findings\\:\\ 0\\.016970237950801215\ \(0\)\
\-\ multiple\\:\\ 0\\.016818314358691917\ \(0\)\
\-\ within\\:\\ 0\\.015836541218965376\ \(0\)\
\-\ which\\:\\ 0\\.01563507379119021\ \(0\)\
\-\ that\\:\\ 0\\.014921678517808424\ \(0\)\
\-\ pain\\:\\ 0\\.012304117821687851\ \(0\)\
\-\ right\\:\\ 0\\.011399957008581514\ \(0\)\
\-\ patient\\:\\ 0\\.011183622902996397\ \(0\)\
\-\ on\\:\\ 0\\.010384775309052007\ \(0\)\
